State Key Laboratory for Oncogenes and Related Genes, Key Laboratory of Gastroenterology & Hepatology, Ministry of Health, Division of Gastroenterology and Hepatology, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai Cancer Institute, Shanghai Institute of Digestive Disease, Shanghai, China.
Expert Rev Gastroenterol Hepatol. 2020 Mar;14(3):155-162. doi: 10.1080/17474124.2020.1732817. Epub 2020 Mar 11.
: Anemia is a common extraintestinal complication of Crohn's disease (CD) mainly caused by iron deficiency, that affects the quality of life in CD patients. Elucidation of the etiology and pathology of iron-deficiency anemia (IDA) and anemia of chronic diseases (ACD) has developed in recent years. Common biochemical parameters of iron status are insufficient for assessment of patients with anemia and CD. Thus, novel iron indices are required for accurate assessment in IDA patients with CD. Oral iron supplementation for IDA treatment is common and is associated with minor gastrointestinal side effects. Intravenous substitution improves safety profiles but may be not tolerable in some patients. Fortunately, additional therapies for anemia of active CD have emerged in recent years.: Here, we propose the review article on the link among anemia, iron deficiency, and Crohn's disease. We discuss the current diagnosis and therapy of anemia and iron deficiency in CD and propose the new directions for future research.: Exploring pathogeneses and treatments of anemia and iron deficiency in Crohn's disease will develop potential tools for early diagnosis and effective treatment of anemia in CD patients, and improve their life quality.
贫血是克罗恩病(CD)常见的肠道外并发症,主要由缺铁引起,影响 CD 患者的生活质量。近年来,铁缺乏性贫血(IDA)和慢性病性贫血(ACD)的病因和发病机制已经阐明。常见的铁状态生化参数不足以评估贫血和 CD 患者的病情。因此,需要新型的铁指标来准确评估 CD 合并 IDA 患者的病情。IDA 治疗中口服补铁很常见,但与轻微的胃肠道副作用有关。静脉替代治疗可提高安全性,但在某些患者中可能无法耐受。幸运的是,近年来针对活动性 CD 贫血的额外治疗方法已经出现。
在这里,我们提出了一篇关于贫血、缺铁和克罗恩病之间联系的综述文章。我们讨论了 CD 中贫血和缺铁的当前诊断和治疗,并为未来的研究提出了新的方向。
探索克罗恩病贫血和缺铁的发病机制和治疗方法,将为 CD 患者的贫血早期诊断和有效治疗开发潜在工具,提高他们的生活质量。